Evaluation of anti-inflammatory effects of Trombovazim in the model of liver ischemia-reperfusion.
Administration of enzyme preparation Trombovazim as a corrector of ischemic damage to animals with experimental liver ischemia-reperfusion reduces neutrophilic infiltration of liver parenchyma and decreases hyperfermentemia, which attests to a decrease in the intensity of destructive changes in hepatocytes.